drugset / Trial / NCT07333742
A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal
RandomizedCrossoverOpen-labelOther
Summary
Bioequivalence study for the fixed-dose combination of gemigliptin/dapagliflozin/metformin 50/10/1000 mg under fed conditions in healthy volunteers
Timeline
- Start
- 2025-09-29
- Primary completion
- 2025-11-27
- Completion
- 2025-11-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dapagliflozin | Small molecule | 10 mg | Oral |
| Subject | Gemigliptin | Small molecule | 50 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |
Indications
No indication recorded.